With the first half of 2026 behind us, we recently reflected on the past three months of the year and all the valuable guidance we’ve seen published by North American and international societies across all medical specialties. Now, with six months still to go in 2026, we are taking a look ahead to guidelines that we anticipate will be published by the end of the year. 

In today's rundown, we are focusing specifically on anticipated guidelines focusing on oncology topics. Links to current versions of the anticipated updates are included where available. Please note that all of the anticipated guideline release windows are our best estimates and the actual release dates may change. The following guidance is listed in alphabetical order.

Most Anticipated Oncology Guidance for Q3 and Q4, 2026
  • Breast Cancer Follow-Up After Primary Treatment
    • American Society of Clinical Oncology (ASCO)
    • Q3 2026
  • Diagnosis and Staging of Non-Small Cell Lung Cancer
  • Differentiated Thyroid Cancer - Thyroid Nodules
  • Hypofractionated Radiation Therapy for Localized Prostate Cancer
    • American Society for Radiation Oncology (ASTRO) / American Society of Clinical Oncology (ASCO) / American Urological Association (AUA)
      Q3 2026
    • Current Version
  • Management of Melanoma
  • Medical Therapy for Hormone Receptor Positive, HER2-Negative Stage I-III Breast Cancer
    • American Society of Clinical Oncology (ASCO)
    • Q3 2026
  • Medullary Thyroid Cancer
  • Radiation Therapy for Adults with Hodgkin Lymphoma
    • American Society for Radiation Oncology (ASTRO)/ American Society of Clinical Oncology ASCO/ European Society for Radiotherapy and Oncology (ESTRO) / International Lymphoma Radiation Oncology Group (ILROG)
    • Q3/Q4 2026
  • Radiation Therapy for Bladder Cancer
    • American Society for Radiation Oncology  (ASTRO), American Urological Association (AUA), Society of Urologic Oncology (SUO), American Society of Clinical Oncology (ASCO), European Society for Radiotherapy and Oncology (ESTRO)
    • Q3 2026
  • Radiation Therapy for Endometrial Cancer
    • American Society for Radiation Oncology (ASTRO) / American Brachytherapy Society (ABS) / American Society of Clinical Oncology (ASCO) / Society of Gynecologic Oncology (SGO)
    • Q3/Q4 2026
    • Current Version
  • Radiation Therapy for Pancreatic Cancer
    • American Society for Radiation Oncology (ASTRO) / American Society of Clinical Oncology (ASCO) / Society of Surgical Oncology (SSO)
    • Q3/Q4 2026
    • Current Version
  • Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline Update
  • Treatment of Multiple Myeloma Living Guideline Update

Be sure to check out our most recently posted oncology-related content and sign up for alerts to stay informed on the latest published guidelines and articles.